Condensed Consolidated Statement Of Cash Flows	6 Months Ended
	Dec. 31, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (34,628,699)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(16,202)
Unrealized gain on marketable securities held in Trust Account	(3,065)
Changes in fair value of warrant liabilities	33,607,289
Changes in operating assets and liabilities:
Prepaid expenses	(34,897)
Accrued expenses	364,275
Net cash used in operating activities	(711,299)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(254,350,000)
Net cash used in investing activities	(254,350,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	249,774,177
Proceeds from sale of Private Warrants	6,837,000
Proceeds from promissory note – related party	150,000
Repayment of promissory note – related party	(150,000)
Payments of offering costs	(421,027)
Net cash provided by financing activities	256,190,150
Net Change in Cash	1,128,851
Cash – Beginning	0
Cash – Ending	1,128,851
Non-Cash investing and financing activities:
Offering costs included in accrued offering costs	2,500
Offering costs paid by Initial Stockholders in exchange for issuance of Founder Shares	25,000
Initial measurement of warrants issued in connection with initial public offering accounted for as liabilities	13,909,673
Initial classification of Class A common stock subject to possible redemption	227,864,040
Change in value of Class A common stock subject to possible redemption	(34,117,018)
Deferred underwriting fee payable	$ 8,902,250